2025-05-02 08:53:03
Latest Post
Godrej Agrovet Limited consolidated Q4FY25 net profit drops QoQ to Rs. 70.78 crores
L G Balakrishnan & Bros Ltd posts Rs. 84.03 crores consolidated profit in Q4FY25
Swastika Investmart Ltd Q4 FY2025 consolidated profit slumps to Rs. 27.17 lakhs
Vertex Securities Ltd consolidated Q4 FY25 loss at Rs. 53.99 lakhs
The Federal Bank Limited consolidated Q4FY25 PAT jumps to Rs. 1108.31 crores
Stock Report
Orchid Pharma Ltd consolidated Q2 FY24 net profit climbs to Rs. 19.80 crores
Posted On : 2023-11-05 23:17:42( TIMEZONE : IST )
Orchid Pharma Limited has reported Consolidated financial results for the period ended September 30, 2023.
Financial Results (Q2 FY2024) - QoQ Comparison
The company has reported total income of Rs. 207.1108 crores during the period ended September 30, 2023 as compared to Rs. 184.8055 crores during the period ended June 30, 2023.
The company has posted net profit / (loss) of Rs. 19.8037 crores for the period ended September 30, 2023 as against net profit / (loss) of Rs. 9.4048 crores for the period ended June 30, 2023.
The company has reported EPS of Rs. 4.30 for the period ended September 30, 2023 as compared to Rs. 1.85 for the period ended June 30, 2023.
| Financials | Q2 FY2024 | Q1 FY2024 | % Change |
| Total Income | ₹ 207.1108 crs | ₹184.8055 crs |  12.07% |
| Net Profit | ₹19.8037 crs | ₹9.4048 crs | 110.57% |
| EPS | ₹4.30 | ₹1.85 | 132.43% |
Financial Results (Q2 FY2024) - YoY Comparison
The company has reported total income of Rs. 207.1108 crores during the period ended September 30, 2023 as compared to Rs.171.0892 crores during the period ended September 30, 2022.
The company has posted net profit / (loss) of Rs.19.8037 crores for the period ended September 30, 2023 as against net profit / (loss) of Rs.-5.3948 crores for the period ended September 30, 2022.
The company has reported EPS of Rs.4.30 for the period ended September 30, 2023 as compared to Rs.-1.32 for the period ended September 30, 2022.
| Financials | Q2 FY2024 | Q2 FY2023 | % Change |
| Total Income | ₹ 207.1108 crs | ₹171.0892 crs | 21.05% |
| Net Profit | ₹19.8037 crs | ₹-5.3948 crs | 467.09% |
| EPS | ₹4.30 | ₹-1.32 | 425.76% |
Financial Results (Half Year Ended FY2024) - YoY Comparison
The company has reported total income of Rs.391.9163 crores during the 6 Months period ended September 30, 2023 as compared to Rs.305.0081 crores during the 6 Months period ended September 30, 2022.
The company has posted net profit / (loss) of Rs.29.2085 crores for the 6 Months period ended September 30, 2023 as against net profit / (loss) of Rs.-20.4082 crores for the 6 Months period ended September 30, 2022.
The company has reported EPS of Rs.6.35 for the 6 Months period ended September 30, 2023 as compared to Rs.-5 for the 6 Months period ended September 30, 2022.
| Financials | Half Year Ended FY2024 | Half Year Ended FY2023 | % Change |
| Total Income | ₹391.9163 crs | ₹305.0081 crs | 28.49% |
| Net Profit | ₹29.2085 crs | ₹-20.4082 crs | 243.12% |
| EPS | ₹6.35 | ₹-5 | 227.00% |
Shares of Orchid Pharma Limited was last trading in BSE at Rs. 492.45 as compared to the previous close of Rs. 489.65. The total number of shares traded during the day was 2081 in over 295 trades.
The stock hit an intraday high of Rs. 499.00 and intraday low of 480.00. The net turnover during the day was Rs. 1015841.00.
